APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosimulation Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biosimulation Software Market Outlook and Growth Opportunities 2026

5 June 2026212 pages

Choose your research edition.

Industry ResearchBiosimulation Software Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimulation Software Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Biosimulation Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimulation Software Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimulation Software Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Biosimulation Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosimulation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biosimulation Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biosimulation Software market include Certara, Simulations, Dassault Systèmes, Schrödinger, Advanced Chemistry, Chemical Computing, Rosa & Co., Genedata and Physiomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biosimulation Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biosimulation Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biosimulation Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biosimulation Software market.

Biosimulation Software Segment by Company

Certara

Simulations

Dassault Systèmes

Schrödinger

Advanced Chemistry

Chemical Computing

Rosa & Co.

Genedata

Physiomics

In Silico Biosciences

Allucent

OpenEye (Cadence)

Cellworks Group

VeriSIM Life

Netabolics SRL

Charnwood Discovery

The MathWorks

ANSYS

Instem Group of Companies

Insilico Medicine

SCM

BioSymetrics

Atomwise

insitro

Clinithink

Biosimulation Software Segment by Type

Independent Modules

Integrated Software Platform

Biosimulation Software Segment by Application

Pharmaceuticals

Medical Research

Others

Biosimulation Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biosimulation Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biosimulation Software key companies, revenue, market share, and recent developments.

3. To split the Biosimulation Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biosimulation Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biosimulation Software significant trends, drivers, influence factors in global and regions.

6. To analyze Biosimulation Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimulation Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimulation Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimulation Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biosimulation Software industry.

Chapter 3: Detailed analysis of Biosimulation Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biosimulation Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biosimulation Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biosimulation Software Industry Trends Table 2. Biosimulation Software Industry Drivers Table 3. Biosimulation Software Industry Opportunities and Challenges Table 4. Biosimulation Software Industry Restraints Table 5. Global Biosimulation Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biosimulation Software Revenue Share by Company (2021-2026) Table 7. Global Biosimulation Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biosimulation Software Key Company Manufacturing Base & Headquarters Table 9. Global Biosimulation Software Company, Product Type & Application Table 10. Global Biosimulation Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biosimulation Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Independent Modules Table 15. Significant Companies of Integrated Software Platform Table 16. Global Biosimulation Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biosimulation Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biosimulation Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biosimulation Software Sales Value Share by Type (2021-2026) Table 20. Global Biosimulation Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceuticals Table 22. Significant Companies of Medical Research Table 23. Significant Companies of Others Table 24. Global Biosimulation Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biosimulation Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Biosimulation Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Biosimulation Software Sales Value Share by Application (2021-2026) Table 28. Global Biosimulation Software Sales Value Share by Application (2027-2032) Table 29. Global Biosimulation Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biosimulation Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Biosimulation Software Sales Value Share by Region (2021-2026) Table 32. Global Biosimulation Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Biosimulation Software Sales Value Share by Region (2027-2032) Table 34. Global Biosimulation Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biosimulation Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Biosimulation Software Sales Value Market Share by Country (2021-2026) Table 37. Global Biosimulation Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Biosimulation Software Sales Value Market Share by Country (2027-2032) Table 39. Certara Company Information Table 40. Certara Business Overview Table 41. Certara Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Certara Biosimulation Software Product Portfolio Table 43. Certara Recent Development Table 44. Simulations Company Information Table 45. Simulations Business Overview Table 46. Simulations Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Simulations Biosimulation Software Product Portfolio Table 48. Simulations Recent Development Table 49. Dassault Systèmes Company Information Table 50. Dassault Systèmes Business Overview Table 51. Dassault Systèmes Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Dassault Systèmes Biosimulation Software Product Portfolio Table 53. Dassault Systèmes Recent Development Table 54. Schrödinger Company Information Table 55. Schrödinger Business Overview Table 56. Schrödinger Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Schrödinger Biosimulation Software Product Portfolio Table 58. Schrödinger Recent Development Table 59. Advanced Chemistry Company Information Table 60. Advanced Chemistry Business Overview Table 61. Advanced Chemistry Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Advanced Chemistry Biosimulation Software Product Portfolio Table 63. Advanced Chemistry Recent Development Table 64. Chemical Computing Company Information Table 65. Chemical Computing Business Overview Table 66. Chemical Computing Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chemical Computing Biosimulation Software Product Portfolio Table 68. Chemical Computing Recent Development Table 69. Rosa & Co. Company Information Table 70. Rosa & Co. Business Overview Table 71. Rosa & Co. Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Rosa & Co. Biosimulation Software Product Portfolio Table 73. Rosa & Co. Recent Development Table 74. Genedata Company Information Table 75. Genedata Business Overview Table 76. Genedata Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Genedata Biosimulation Software Product Portfolio Table 78. Genedata Recent Development Table 79. Physiomics Company Information Table 80. Physiomics Business Overview Table 81. Physiomics Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Physiomics Biosimulation Software Product Portfolio Table 83. Physiomics Recent Development Table 84. In Silico Biosciences Company Information Table 85. In Silico Biosciences Business Overview Table 86. In Silico Biosciences Biosimulation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. In Silico Biosciences Biosimulation Software Product Portfolio Table 88. In Silico Biosciences Recent Development Table 89. Allucent Company Information Table 90. Allucent Business Overview Table 91. Allucent Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Allucent Biosimulation Software Product Portfolio Table 93. Allucent Recent Development Table 94. OpenEye (Cadence) Company Information Table 95. OpenEye (Cadence) Business Overview Table 96. OpenEye (Cadence) Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. OpenEye (Cadence) Biosimulation Software Product Portfolio Table 98. OpenEye (Cadence) Recent Development Table 99. Cellworks Group Company Information Table 100. Cellworks Group Business Overview Table 101. Cellworks Group Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Cellworks Group Biosimulation Software Product Portfolio Table 103. Cellworks Group Recent Development Table 104. VeriSIM Life Company Information Table 105. VeriSIM Life Business Overview Table 106. VeriSIM Life Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. VeriSIM Life Biosimulation Software Product Portfolio Table 108. VeriSIM Life Recent Development Table 109. Netabolics SRL Company Information Table 110. Netabolics SRL Business Overview Table 111. Netabolics SRL Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Netabolics SRL Biosimulation Software Product Portfolio Table 113. Netabolics SRL Recent Development Table 114. Charnwood Discovery Company Information Table 115. Charnwood Discovery Business Overview Table 116. Charnwood Discovery Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Charnwood Discovery Biosimulation Software Product Portfolio Table 118. Charnwood Discovery Recent Development Table 119. The MathWorks Company Information Table 120. The MathWorks Business Overview Table 121. The MathWorks Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. The MathWorks Biosimulation Software Product Portfolio Table 123. The MathWorks Recent Development Table 124. ANSYS Company Information Table 125. ANSYS Business Overview Table 126. ANSYS Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. ANSYS Biosimulation Software Product Portfolio Table 128. ANSYS Recent Development Table 129. Instem Group of Companies Company Information Table 130. Instem Group of Companies Business Overview Table 131. Instem Group of Companies Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Instem Group of Companies Biosimulation Software Product Portfolio Table 133. Instem Group of Companies Recent Development Table 134. Insilico Medicine Company Information Table 135. Insilico Medicine Business Overview Table 136. Insilico Medicine Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Insilico Medicine Biosimulation Software Product Portfolio Table 138. Insilico Medicine Recent Development Table 139. SCM Company Information Table 140. SCM Business Overview Table 141. SCM Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. SCM Biosimulation Software Product Portfolio Table 143. SCM Recent Development Table 144. BioSymetrics Company Information Table 145. BioSymetrics Business Overview Table 146. BioSymetrics Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. BioSymetrics Biosimulation Software Product Portfolio Table 148. BioSymetrics Recent Development Table 149. Atomwise Company Information Table 150. Atomwise Business Overview Table 151. Atomwise Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Atomwise Biosimulation Software Product Portfolio Table 153. Atomwise Recent Development Table 154. insitro Company Information Table 155. insitro Business Overview Table 156. insitro Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. insitro Biosimulation Software Product Portfolio Table 158. insitro Recent Development Table 159. Clinithink Company Information Table 160. Clinithink Business Overview Table 161. Clinithink Biosimulation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Clinithink Biosimulation Software Product Portfolio Table 163. Clinithink Recent Development Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Biosimulation Software Product Image Figure 2. Global Biosimulation Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biosimulation Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Biosimulation Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Independent Modules Image Figure 8. Integrated Software Platform Image Figure 9. Global Biosimulation Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biosimulation Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biosimulation Software Sales Value Share by Type (2021-2032) Figure 12. Pharmaceuticals Image Figure 13. Medical Research Image Figure 14. Others Image Figure 15. Global Biosimulation Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biosimulation Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Biosimulation Software Sales Value Share by Application (2021-2032) Figure 18. Global Biosimulation Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Biosimulation Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Biosimulation Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Biosimulation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Biosimulation Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Biosimulation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Biosimulation Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Biosimulation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Biosimulation Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Biosimulation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Biosimulation Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Biosimulation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Biosimulation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Biosimulation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Biosimulation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Independent Modules
  • Integrated Software Platform
Applications
  • Pharmaceuticals
  • Medical Research
  • Others
Companies covered
  • Certara
  • Simulations
  • Dassault Systèmes
  • Schrödinger
  • Advanced Chemistry
  • Chemical Computing
  • Rosa & Co.
  • Genedata
  • Physiomics
  • In Silico Biosciences
  • Allucent
  • OpenEye (Cadence)
  • Cellworks Group
  • VeriSIM Life
  • Netabolics SRL
  • Charnwood Discovery
  • The MathWorks
  • ANSYS
  • Instem Group of Companies
  • Insilico Medicine
  • SCM
  • BioSymetrics
  • Atomwise
  • insitro
  • Clinithink

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biosimulation Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biosimulation Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biosimulation Software Market Dynamics
  1. 2.1 Biosimulation Software Industry Trends
  2. 2.2 Biosimulation Software Industry Drivers
  3. 2.3 Biosimulation Software Industry Opportunities and Challenges
  4. 2.4 Biosimulation Software Industry Restraints
3 Biosimulation Software Market by Company
  1. 3.1 Global Biosimulation Software Company Revenue Ranking in 2025
  2. 3.2 Global Biosimulation Software Revenue by Company (2021-2026)
  3. 3.3 Global Biosimulation Software Company Ranking (2024-2026)
  4. 3.4 Global Biosimulation Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Biosimulation Software Company Product Type and Application
  6. 3.6 Global Biosimulation Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biosimulation Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biosimulation Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biosimulation Software Market by Type
  1. 4.1 Biosimulation Software Type Introduction
  2. 4.1.1 Independent Modules
  3. 4.1.2 Integrated Software Platform
  4. 4.2 Global Biosimulation Software Sales Value by Type
  5. 4.2.1 Global Biosimulation Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biosimulation Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biosimulation Software Sales Value Share by Type (2021-2032)
5 Biosimulation Software Market by Application
  1. 5.1 Biosimulation Software Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Medical Research
  4. 5.1.3 Others
  5. 5.2 Global Biosimulation Software Sales Value by Application
  6. 5.2.1 Global Biosimulation Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biosimulation Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biosimulation Software Sales Value Share by Application (2021-2032)
6 Biosimulation Software Regional Value Analysis
  1. 6.1 Global Biosimulation Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biosimulation Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biosimulation Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biosimulation Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biosimulation Software Sales Value (2021-2032)
  7. 6.3.2 North America Biosimulation Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biosimulation Software Sales Value (2021-2032)
  10. 6.4.2 Europe Biosimulation Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biosimulation Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biosimulation Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biosimulation Software Sales Value (2021-2032)
  16. 6.6.2 South America Biosimulation Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biosimulation Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biosimulation Software Sales Value Share by Country, 2025 VS 2032
7 Biosimulation Software Country-level Value Analysis
  1. 7.1 Global Biosimulation Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biosimulation Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biosimulation Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biosimulation Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biosimulation Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biosimulation Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biosimulation Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biosimulation Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biosimulation Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biosimulation Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biosimulation Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biosimulation Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biosimulation Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biosimulation Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biosimulation Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biosimulation Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biosimulation Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biosimulation Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biosimulation Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biosimulation Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biosimulation Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biosimulation Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biosimulation Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biosimulation Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biosimulation Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biosimulation Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biosimulation Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biosimulation Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biosimulation Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biosimulation Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biosimulation Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biosimulation Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biosimulation Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biosimulation Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biosimulation Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Certara
  2. 8.1.1 Certara Company Information
  3. 8.1.2 Certara Business Overview
  4. 8.1.3 Certara Biosimulation Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Certara Biosimulation Software Product Portfolio
  6. 8.1.5 Certara Recent Developments
  7. 8.2 Simulations
  8. 8.2.1 Simulations Company Information
  9. 8.2.2 Simulations Business Overview
  10. 8.2.3 Simulations Biosimulation Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Simulations Biosimulation Software Product Portfolio
  12. 8.2.5 Simulations Recent Developments
  13. 8.3 Dassault Systèmes
  14. 8.3.1 Dassault Systèmes Company Information
  15. 8.3.2 Dassault Systèmes Business Overview
  16. 8.3.3 Dassault Systèmes Biosimulation Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dassault Systèmes Biosimulation Software Product Portfolio
  18. 8.3.5 Dassault Systèmes Recent Developments
  19. 8.4 Schrödinger
  20. 8.4.1 Schrödinger Company Information
  21. 8.4.2 Schrödinger Business Overview
  22. 8.4.3 Schrödinger Biosimulation Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Schrödinger Biosimulation Software Product Portfolio
  24. 8.4.5 Schrödinger Recent Developments
  25. 8.5 Advanced Chemistry
  26. 8.5.1 Advanced Chemistry Company Information
  27. 8.5.2 Advanced Chemistry Business Overview
  28. 8.5.3 Advanced Chemistry Biosimulation Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Advanced Chemistry Biosimulation Software Product Portfolio
  30. 8.5.5 Advanced Chemistry Recent Developments
  31. 8.6 Chemical Computing
  32. 8.6.1 Chemical Computing Company Information
  33. 8.6.2 Chemical Computing Business Overview
  34. 8.6.3 Chemical Computing Biosimulation Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chemical Computing Biosimulation Software Product Portfolio
  36. 8.6.5 Chemical Computing Recent Developments
  37. 8.7 Rosa & Co.
  38. 8.7.1 Rosa & Co. Company Information
  39. 8.7.2 Rosa & Co. Business Overview
  40. 8.7.3 Rosa & Co. Biosimulation Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Rosa & Co. Biosimulation Software Product Portfolio
  42. 8.7.5 Rosa & Co. Recent Developments
  43. 8.8 Genedata
  44. 8.8.1 Genedata Company Information
  45. 8.8.2 Genedata Business Overview
  46. 8.8.3 Genedata Biosimulation Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genedata Biosimulation Software Product Portfolio
  48. 8.8.5 Genedata Recent Developments
  49. 8.9 Physiomics
  50. 8.9.1 Physiomics Company Information
  51. 8.9.2 Physiomics Business Overview
  52. 8.9.3 Physiomics Biosimulation Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Physiomics Biosimulation Software Product Portfolio
  54. 8.9.5 Physiomics Recent Developments
  55. 8.10 In Silico Biosciences
  56. 8.10.1 In Silico Biosciences Company Information
  57. 8.10.2 In Silico Biosciences Business Overview
  58. 8.10.3 In Silico Biosciences Biosimulation Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 In Silico Biosciences Biosimulation Software Product Portfolio
  60. 8.10.5 In Silico Biosciences Recent Developments
  61. 8.11 Allucent
  62. 8.11.1 Allucent Company Information
  63. 8.11.2 Allucent Business Overview
  64. 8.11.3 Allucent Biosimulation Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Allucent Biosimulation Software Product Portfolio
  66. 8.11.5 Allucent Recent Developments
  67. 8.12 OpenEye (Cadence)
  68. 8.12.1 OpenEye (Cadence) Company Information
  69. 8.12.2 OpenEye (Cadence) Business Overview
  70. 8.12.3 OpenEye (Cadence) Biosimulation Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 OpenEye (Cadence) Biosimulation Software Product Portfolio
  72. 8.12.5 OpenEye (Cadence) Recent Developments
  73. 8.13 Cellworks Group
  74. 8.13.1 Cellworks Group Company Information
  75. 8.13.2 Cellworks Group Business Overview
  76. 8.13.3 Cellworks Group Biosimulation Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cellworks Group Biosimulation Software Product Portfolio
  78. 8.13.5 Cellworks Group Recent Developments
  79. 8.14 VeriSIM Life
  80. 8.14.1 VeriSIM Life Company Information
  81. 8.14.2 VeriSIM Life Business Overview
  82. 8.14.3 VeriSIM Life Biosimulation Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 VeriSIM Life Biosimulation Software Product Portfolio
  84. 8.14.5 VeriSIM Life Recent Developments
  85. 8.15 Netabolics SRL
  86. 8.15.1 Netabolics SRL Company Information
  87. 8.15.2 Netabolics SRL Business Overview
  88. 8.15.3 Netabolics SRL Biosimulation Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Netabolics SRL Biosimulation Software Product Portfolio
  90. 8.15.5 Netabolics SRL Recent Developments
  91. 8.16 Charnwood Discovery
  92. 8.16.1 Charnwood Discovery Company Information
  93. 8.16.2 Charnwood Discovery Business Overview
  94. 8.16.3 Charnwood Discovery Biosimulation Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Charnwood Discovery Biosimulation Software Product Portfolio
  96. 8.16.5 Charnwood Discovery Recent Developments
  97. 8.17 The MathWorks
  98. 8.17.1 The MathWorks Company Information
  99. 8.17.2 The MathWorks Business Overview
  100. 8.17.3 The MathWorks Biosimulation Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 The MathWorks Biosimulation Software Product Portfolio
  102. 8.17.5 The MathWorks Recent Developments
  103. 8.18 ANSYS
  104. 8.18.1 ANSYS Company Information
  105. 8.18.2 ANSYS Business Overview
  106. 8.18.3 ANSYS Biosimulation Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ANSYS Biosimulation Software Product Portfolio
  108. 8.18.5 ANSYS Recent Developments
  109. 8.19 Instem Group of Companies
  110. 8.19.1 Instem Group of Companies Company Information
  111. 8.19.2 Instem Group of Companies Business Overview
  112. 8.19.3 Instem Group of Companies Biosimulation Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Instem Group of Companies Biosimulation Software Product Portfolio
  114. 8.19.5 Instem Group of Companies Recent Developments
  115. 8.20 Insilico Medicine
  116. 8.20.1 Insilico Medicine Company Information
  117. 8.20.2 Insilico Medicine Business Overview
  118. 8.20.3 Insilico Medicine Biosimulation Software Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Insilico Medicine Biosimulation Software Product Portfolio
  120. 8.20.5 Insilico Medicine Recent Developments
  121. 8.21 SCM
  122. 8.21.1 SCM Company Information
  123. 8.21.2 SCM Business Overview
  124. 8.21.3 SCM Biosimulation Software Revenue and Gross Margin (2021-2026)
  125. 8.21.4 SCM Biosimulation Software Product Portfolio
  126. 8.21.5 SCM Recent Developments
  127. 8.22 BioSymetrics
  128. 8.22.1 BioSymetrics Company Information
  129. 8.22.2 BioSymetrics Business Overview
  130. 8.22.3 BioSymetrics Biosimulation Software Revenue and Gross Margin (2021-2026)
  131. 8.22.4 BioSymetrics Biosimulation Software Product Portfolio
  132. 8.22.5 BioSymetrics Recent Developments
  133. 8.23 Atomwise
  134. 8.23.1 Atomwise Company Information
  135. 8.23.2 Atomwise Business Overview
  136. 8.23.3 Atomwise Biosimulation Software Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Atomwise Biosimulation Software Product Portfolio
  138. 8.23.5 Atomwise Recent Developments
  139. 8.24 insitro
  140. 8.24.1 insitro Company Information
  141. 8.24.2 insitro Business Overview
  142. 8.24.3 insitro Biosimulation Software Revenue and Gross Margin (2021-2026)
  143. 8.24.4 insitro Biosimulation Software Product Portfolio
  144. 8.24.5 insitro Recent Developments
  145. 8.25 Clinithink
  146. 8.25.1 Clinithink Company Information
  147. 8.25.2 Clinithink Business Overview
  148. 8.25.3 Clinithink Biosimulation Software Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Clinithink Biosimulation Software Product Portfolio
  150. 8.25.5 Clinithink Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst